Skip to main content

Table 4 Health chronic problems declared by the study population

From: Use of medical services and medicines attributable to type 2 diabetes care in Yaoundé, Cameroon: a cross-sectional study

Chronic diseases People with T2D
n (%)
People without diabetes
n (%)
p-value* OR (95% CI)** p-value**
Hypertension 250 (50.1) 79 (15.8) <0.001 9.2 (5.0–16.9) <0.001
Cardiovascular diseases 47 (9.4) 21 (4.2) <0.01 1.9 (0.8–4.9) <0.01
Peripheral neuropathy 271 (54.2) 117 (23.5) <0.001 6.2 (3.4–11.3) <0.001
Erectile dysfunction or loss of libido 143 (29.3) 52 (10.4) <0.001 5.79 (2.7–12.2) <0.001
Foot or leg ulcer/Amputation 30 (6) 9 (1.8) <0.001 2.5 (0.7–8.4) >0.05
Kidney diseases 39 (7.8) 18 (3.6) <0.01 0.8 (0.3–2.3) >0.05
Eyes diseases 49 (9.8) 21 (4.2) <0.001 1.6 (0.7–3.4) >0.05
Depression 25 (5) 7 (1.4) <0.01 7.6 (1.4–65.9) >0.05
Cancer 5 (1) 3 (0.6) 0.7 - -
Lung diseases 28 (5.6) 27 (5.4) 1 0.8 (0.3–2.1) >0.05
HIV/AIDSa 5 (1) 6 (1.2) 1 0.8 (0.2–3.8) >0.05
Comorbidity number    <0.001***   
 0 68 (13.6) 194 (38.8)   
 1 122 (24.4) 174 (34.8)   
  ≥ 2 310 (62) 132 (26.4)   
  1. *p-value from paired t-test; **OR and p-value from multivariate logistic regression; ***p-value from the Stuart-Maxwell test
  2. aHIV/AIDS: Human Immunodeficiency Virus infection and Acquired Immune Deficiency Syndrome